Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: Population based cohort study

BMJ (Online)

Volumn 339, Issue 7723, 2009, Pages 735-

  Pedersen, Lars Henning ^a,b   Henriksen, Tine Brink ^c   Vestergaard, Mogens ^a   Olsen, Jørn ^b   Bech, Bodil Hammer ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ARTICLE; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DIAPHRAGM HERNIA; FEMALE; GASTROINTESTINAL MALFORMATION; GASTROSCHISIS; GENITAL MALFORMATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; OMPHALOCELE; PREGNANCY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS; CHILD; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 70349432273     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3569     Document Type: Article

References (25)

1. Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001;323:257-260 (Pubitemid 32729111)
2. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698-709. (Pubitemid 40459031)
3. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-1015 (Pubitemid 26338730)
4. Ericson A, Kallen B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999;55:503-508 (Pubitemid 29446550)
5. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159:2055-2061
6. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-1296 (Pubitemid 41668948)
7. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005;14:823-827 (Pubitemid 43056107)
8. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356:2684-2692 (Pubitemid 47001036)
9. Kallen B, Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006;21:221-222 (Pubitemid 43294548)
10. Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 2007;29:918-926 (Pubitemid 47223423)
11. Wogelius P, Norgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006;17:701-704 (Pubitemid 44655607)
12. Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007;80:18-27. (Pubitemid 46303265)
13. Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-2683 (Pubitemid 47001035)
14. GlaxoSmithKline. Updated preliminary report on bupropion and the outcome of cardiovascular and major congenital malformation. 2007. http://ctr.gsk.co.uk/ Summary/paroxetine/studylist.asp.
15. Food Drug Administration, USA. FDA public health advisory, paroxetine. 2005. www.fda.gov/medwatch/safety/2005/safety05.htm#Paxil2.
16. Knudsen LB, Olsen J. The Danish medical birth registry. Dan Med Bull 1998;45:320-323
17. Knudsen LB. The Danish fertility database. Dan Med Bull 1998;45:221-225
18. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-268
19. WHO Collaborating Centre for Drug Statistics Methodology. The ATC classification - structure and principles. 2008. www.whocc.no/atcddd.
20. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sorensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health 2003;31:12-16 (Pubitemid 40990826)
21. Dolk H. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 2005;90(5):F355-8. (Pubitemid 41224066)
22. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176-184 (Pubitemid 34072741)
23. Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76. (Pubitemid 351317794)
24. Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 2008;66:695-705.
25. International Epidemiological Association (IEA). Good epidemiological practice - IEA guidelines for proper conduct of epidemiological research. 2007. http://www.dundee.ac.uk/iea/GEP07.htm.